1-5 of 5
Ying-Chun Shen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

Open Access
Subject Area:
Oncology
Derek De-Rui Huang, Bin-Chi Liao, Wei-Hsun Hsu, Ching-Yao Yang, Yen-Ting Lin, Shang-Gin Wu, Tzu-Hsiu Tsai, Kuan-Yu Chen, Chao-Chi Ho, Wei-Yu Liao, Jin-Yuan Shih, Chong-Jen Yu, James Chih-Hsin Yang, Ann-Lii Cheng, Ying-Chun Shen
Journal: Oncology
Oncology (2024) 102 (4): 318–326.
https://doi.org/10.1159/000534350
Published Online: 29 September 2023
View articletitled, Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
Open the PDF for Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors in another window
Journal Articles

Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer

Available to Purchase
Subject Area:
Oncology
Ying-Chun Shen, Chung-Pin Li, Chia-Jui Yen, Chiun Hsu, Yu-Lin Lin, Zhong-Zhe Lin, Li-Tzong Chen, Wu-Chou Su, Yee Chao, Kun-Huei Yeh, Ann-Lii Cheng
Journal: Oncology
Oncology (2014) 87 (2): 104–113.
https://doi.org/10.1159/000362671
Published Online: 04 July 2014
View articletitled, Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
Open the PDF for Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer in another window
Journal Articles

A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-Regression

Available to Purchase
Subject Area:
Oncology
Ying-Chun Shen, Chiun Hsu, Chia-Chi Cheng, Fu-Chang Hu, Ann-Lii Cheng
Journal: Oncology
Oncology (2012) 82 (5): 275–289.
https://doi.org/10.1159/000337293
Published Online: 27 April 2012
View articletitled, A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-Regression
Open the PDF for A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-Regression in another window
Journal Articles

Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Ann-Lii Cheng, Ying-Chun Shen, Andrew X. Zhu
Journal: Oncology
Oncology (2012) 81 (5-6): 372–380.
https://doi.org/10.1159/000335472
Published Online: 20 January 2012
View articletitled, Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma
Open the PDF for Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma in another window
Journal Articles

High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic Chemotherapy

Available to Purchase
Subject Area:
Oncology
Yu-Yun Shao, Zhong-Zhe Lin, Te-Jung Chen, Chiun Hsu, Ying-Chun Shen, Chih-Hung Hsu, Ann-Lii Cheng
Journal: Oncology
Oncology (2011) 81 (2): 98–103.
https://doi.org/10.1159/000331684
Published Online: 04 October 2011
View articletitled, High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic Chemotherapy
Open the PDF for High Circulating Endothelial Progenitor Levels Associated with Poor Survival of Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib Combined with Metronomic Chemotherapy in another window